Association between pregnancy, reproductive hormones, and lung cancer risk: a systematic review
Folia Medica · 22.10.2025 · 67 (5)
DOI: 10.3897/folmed.67.e156329 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Folia Medica, online erschienen am 22.10.2025. Verfasst von Eleni-Maria Sotiropoulou und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of West Attica, Athens, Greece. Hauptthemen laut MEDLINE: Lung Neoplasms, Parity, Pregnancy Complications, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Abstract Lung cancer remains the leading cause of cancer-related mortality worldwide, with unique epidemiological and molecular patterns observed in women. Smoking is the primary risk factor for lung cancer. However, a significant number of cases in female never-smokers suggest other contributors, including reproductive and hormonal factors. This systematic review synthesizes evidence on the association between pregnancy, reproductive hormones, and lung cancer risk, with a focus on pregnancy-associated lung cancer (PALC). Key findings include the protective role of higher parity, later menopause, and prolonged reproductive periods, attributed to hormonal stabilization and immune modulation. PALC, though rare, presents distinct challenges due to diagnostic delays and the need for pregnancy-specific treatment strategies. Molecular profiling highlights a high prevalence of actionable mutations, such as anaplastic lymphoma kinase (ALK) rearrangements and epidermal growth factor receptor (EGFR) mutations, offering potential targets for therapy. However, the analysis also underscores significant gaps in knowledge. Confounding factors, particularly smoking, and heterogeneity in study designs limit causal inferences. Future research should prioritize large-scale cohort studies and mechanistic investigations to elucidate hormonal and genetic interactions. Clinically, integrating reproductive history into lung cancer risk models could enhance early detection and personalized management strategies, particularly in high-risk subgroups. This review contributes to the growing understanding of hormonal influences on lung cancer, emphasizing their potential as biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of West Attica, Athens, Greece.
- National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Vasiliki Epameinondas Georgakopoulou
Zitieren
APA
Sotiropoulou, E. M., Sarantaki, A., Georgakopoulou, V. E., Kyrkou, G., & Diamanti, A. (2025). Association between pregnancy, reproductive hormones, and lung cancer risk: a systematic review. Folia Medica, 67(5). https://doi.org/10.3897/folmed.67.e156329
Vancouver
Sotiropoulou EM, Sarantaki A, Georgakopoulou VE, Kyrkou G, Diamanti A. Association between pregnancy, reproductive hormones, and lung cancer risk: a systematic review. Folia Medica. 2025;67(5). doi:10.3897/folmed.67.e156329
BibTeX
@article{Sotiropoulou2025,
author = {Sotiropoulou, Eleni-Maria and Sarantaki, Antigoni and Georgakopoulou, Vasiliki Epameinondas and Kyrkou, Giannoula and Diamanti, Athina},
title = {Association between pregnancy, reproductive hormones, and lung cancer risk: a systematic review},
journal = {Folia Medica},
year = {2025},
volume = {67},
number = {5},
doi = {10.3897/folmed.67.e156329}
}
EUVIMED